It is time for Jon Dudas to show true leadership
Well, it’s four days now since GlaxoSmithKline obtained its injunction preventing the USPTO’s new claims and continuations rules from coming into force. Not being a lawyer I have no idea whether the injunction will turn into something more permanent…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.